Active Biotech AB

251 articles about Active Biotech AB

• Active Biotech AB Year-End Report January - December 2013

  2/13/2014

• Teva Pharmaceutical Industries Limited, Active Biotech AB's NERVENTRA® Fails To Win European Medicines Agency Backing; Both Companies Remain Committed To The Drug

  1/24/2014

• Active Biotech AB To Present At The 32nd Annual J.P. Morgan Healthcare Conference

  1/9/2014

• Active Biotech AB Release: Laquinimod CHMP/European Medicines Agency Opinion

  12/20/2013

• Active Biotech AB to Present at the Jefferies and Co. 2013 Global Healthcare Conference

  11/14/2013

• Active Biotech AB's Election Committee Appointed

  11/11/2013

• Active Biotech AB Interim Report January - September 2013

  11/7/2013

• Active Biotech AB's Partner Teva Pharmaceutical Industries Limited Initiates a Further Clinical Trial in Multiple Sclerosis

  11/4/2013

• Active Biotech AB Receives Tasquinimod Milestone Payment From Ipsen for 10TASQ10 Study

  10/9/2013

• Active Biotech AB Receives Tasquinimod Milestone Payment From Ipsen for 10TASQ10 Study

  10/9/2013

• Active Biotech AB and Teva Pharmaceutical Industries Limited Release: Newly Published Phase 3 Exploratory Analysis Suggests Investigational Oral Laquinimod for Multiple Sclerosis May Reduce Brain Damage Caused by Neurodegeneration

  10/1/2013

• Active Biotech AB's Project ANYARA Will Be Presented at the European Cancer Congress 2013

  9/12/2013

• Active Biotech AB to Present at the Rodman & Renshaw Annual Global Investment Conference

  9/5/2013

• Active Biotech AB Interim Report January - June 2013

  8/7/2013

• Active Biotech AB Interim Report January - June 2013

  8/7/2013

• Teva Pharmaceutical Industries Limited to Present at the Wells Fargo 2013 Healthcare Conference

  6/12/2013

• Teva Pharmaceutical Industries Limited and Active Biotech AB Report Positive Results From Phase IIa Study of Laquinimod in Active Lupus Nephritis

  6/12/2013

• EXINI and Active Biotech AB Present Impact of Tasquinimod on Bone Metastases as Measured by Bone Scan Index (BSI)

  6/3/2013

• Active Biotech AB's Project ANYARA Improved Overall Survival in a Subgroup of Renal Cell Cancer Patients

  6/3/2013

• Active Biotech AB to Present at the Jefferies and Co. 2013 Global Healthcare Conference

  5/30/2013